{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:01:32Z","timestamp":1792008092686,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T00:00:00Z","timestamp":1442880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"REDINREN","award":["RD012\/0021"],"award-info":[{"award-number":["RD012\/0021"]}]},{"name":"AITER"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.nefro.2015.09.008","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T22:25:57Z","timestamp":1446503157000},"page":"554-561","source":"Crossref","is-referenced-by-count":16,"title":["Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin\u2013angiotensin\u2013aldosterone system among patients with obesity and proteinuria"],"prefix":"10.1016","volume":"35","author":[{"given":"Enrique","family":"Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jara","family":"Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Sevillano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rojas-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Praga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2015.09.008_bib0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease","volume":"144","author":"Hsu","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefro.2015.09.008_bib0165","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/ndt\/gfg427","article-title":"After all those fat years: renal consequences of obesity","volume":"18","author":"Wolf","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.09.008_bib0170","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.mnh.0000242172.06459.7c","article-title":"Obesity, proteinuria and progression of renal failure","volume":"15","author":"Praga","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nefro.2015.09.008_bib0175","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: an emerging epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.09.008_bib0180","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/ndt\/17.7.1157","article-title":"Obesity-a neglected culprit in renal disease","volume":"17","author":"Praga","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.09.008_bib0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1523-1755.2005.00401.x","article-title":"Factors influencing the progresi\u00f3n of renal damage in patients with unilateral renal agenesis and remmant kidney","volume":"68","author":"Gonz\u00e1lez","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.09.008_bib0190","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0272-6386(01)80120-7","article-title":"Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis","volume":"37","author":"Bonnet","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefro.2015.09.008_bib0195","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1172\/JCI27699","article-title":"Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes","volume":"116","author":"Remuzzi","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nefro.2015.09.008_bib0200","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"De Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefro.2015.09.008_bib0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","article-title":"Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data","volume":"135","author":"Jafar","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nefro.2015.09.008_bib0210","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjmed.2006.03.038","article-title":"Aldosterone blockade: an emerging strategy for abrogating progressive renal disease","volume":"119","author":"Epstein","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.nefro.2015.09.008_bib0215","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.CIR.0000161831.07637.63","article-title":"Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade","volume":"111","author":"Xu","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.nefro.2015.09.008_bib0220","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","article-title":"Weight loss and the renin\u2013angiotensin\u2013aldosterone system","volume":"45","author":"Engeli","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.nefro.2015.09.008_bib0225","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1681\/ASN.2010090969","article-title":"ACE inhibition is renoprotective among obese patients with proteinuria","volume":"22","author":"Mallamaci","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.09.008_bib0230","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/HYPERTENSIONAHA.107.109439","article-title":"Aldosterone and metabolic syndrome: is increased aldosterone in metabolic syndrome patients an additional risk factor?","volume":"51","author":"Krug","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.nefro.2015.09.008_bib0235","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1681\/ASN.2006080944","article-title":"Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors","volume":"17","author":"Nagase","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.09.008_bib0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.HYP.0000105624.68174.00","article-title":"Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration","volume":"43","author":"De Paula","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.nefro.2015.09.008_bib0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000334961","article-title":"Mineralocorticoid receptor blocker protects against podocyte-dependent glomerulosclerosis","volume":"2","author":"Takagi","year":"2012","journal-title":"Nephron Extra"},{"issue":"5","key":"10.1016\/j.nefro.2015.09.008_bib0250","first-page":"421","article-title":"The antiproteinuric effect of the blockage of the renin\u2013angiotensin\u2013aldosterone system (RAAS) in obese patients. Which treatment option is the most effective?","volume":"29","author":"Morales","year":"2009","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefro.2015.09.008_bib0255","doi-asserted-by":"crossref","first-page":"449","DOI":"10.5414\/CNP72449","article-title":"Low-dose spironolactone, added to long-term ACE inhibitor therapy, reduces blood pressure and urinary albumin excretion in obese patients with hypertensive target organ damage","volume":"72","author":"Bomback","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nefro.2015.09.008_bib0260","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ndt\/gfs429","article-title":"Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases","volume":"28","author":"Morales","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl. 4","key":"10.1016\/j.nefro.2015.09.008_bib0265","first-page":"iv8","article-title":"Adipokines promote chronic kidney disease","volume":"28","author":"R\u00fcster","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.09.008_bib0270","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000209744","article-title":"Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review","volume":"30","author":"Bomback","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nefro.2015.09.008_bib0275","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.2336140100","article-title":"Human adipocytes secrete mineralocorticoid-releasing factors","volume":"10","author":"Ehrhart-Bornstein","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nefro.2015.09.008_bib0280","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.HYP.0000113294.06704.64","article-title":"Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy","volume":"43","author":"Goodfriend","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.nefro.2015.09.008_bib0285","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2015.09.008_bib0290","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefro.2015.09.008_bib0295","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pcad.2009.12.004","article-title":"Aldosterone: role in the cardiometabolic syndrome and resistant hypertension","volume":"52","author":"Whaley-Connel","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.nefro.2015.09.008_bib0300","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2007060693","article-title":"Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan","volume":"19","author":"Vogt","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2015.09.008_bib0305","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/ndt\/gfp776","article-title":"Diuretic uptritation with half dose combined ACEI+ARB better decrease proteinuria than combined ACEI+ARB uptitration","volume":"25","author":"Esnault","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefro.2015.09.008_bib0310","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1681\/ASN.2004060505","article-title":"Diuretic and enhaced sodium restriction results in improved antiproteinuric response to RAS blocking agents","volume":"16","author":"Esnault","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699515001472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699515001472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T03:26:12Z","timestamp":1537241172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699515001472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0211699515001472"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2015.09.008","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}